Laura Rubbia‐Brandt

14.8k total citations · 2 hit papers
210 papers, 10.3k citations indexed

About

Laura Rubbia‐Brandt is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Laura Rubbia‐Brandt has authored 210 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Hepatology, 93 papers in Epidemiology and 68 papers in Surgery. Recurrent topics in Laura Rubbia‐Brandt's work include Liver Disease Diagnosis and Treatment (77 papers), Hepatocellular Carcinoma Treatment and Prognosis (47 papers) and Liver Disease and Transplantation (28 papers). Laura Rubbia‐Brandt is often cited by papers focused on Liver Disease Diagnosis and Treatment (77 papers), Hepatocellular Carcinoma Treatment and Prognosis (47 papers) and Liver Disease and Transplantation (28 papers). Laura Rubbia‐Brandt collaborates with scholars based in Switzerland, United States and France. Laura Rubbia‐Brandt's co-authors include Gilles Mentha, Emiliano Giostra, Laurent Spahr, Antoine Hadengue, Pietro Majno, Francesco Negro, A. Roth, Philippe Morel, Benoît Terris and Alexis Desmoulière and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Laura Rubbia‐Brandt

201 papers receiving 10.1k citations

Hit Papers

Severe hepatic sinusoidal obstruction associated with oxa... 2004 2026 2011 2018 2004 2015 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Rubbia‐Brandt Switzerland 53 5.9k 4.1k 3.1k 2.9k 1.4k 210 10.3k
Olivier Rosmorduc France 43 4.6k 0.8× 3.0k 0.7× 2.4k 0.8× 2.3k 0.8× 1.3k 0.9× 129 8.0k
Rong Guo China 43 5.1k 0.9× 2.5k 0.6× 1.8k 0.6× 2.2k 0.8× 1.4k 1.0× 255 8.8k
Andrew D. Clouston Australia 57 3.8k 0.7× 4.9k 1.2× 2.4k 0.8× 2.7k 0.9× 1.4k 1.0× 197 11.4k
Shuichiro Shiina Japan 53 7.3k 1.2× 5.2k 1.3× 1.7k 0.6× 2.5k 0.9× 1.1k 0.8× 224 10.9k
Dominique Wendum France 49 3.9k 0.7× 3.7k 0.9× 1.1k 0.3× 2.4k 0.8× 1.4k 1.0× 149 7.5k
Takashi Kumada Japan 54 8.6k 1.5× 6.9k 1.7× 1.7k 0.5× 2.0k 0.7× 1.4k 1.0× 399 11.7k
Iwao Ikai Japan 54 6.6k 1.1× 3.5k 0.9× 2.1k 0.7× 4.1k 1.4× 1.7k 1.2× 221 10.3k
Akinobu Taketomi Japan 60 6.2k 1.1× 3.5k 0.9× 3.1k 1.0× 5.6k 1.9× 2.4k 1.7× 634 13.1k
Geum‐Youn Gwak South Korea 44 4.8k 0.8× 4.9k 1.2× 1.3k 0.4× 1.7k 0.6× 1.5k 1.1× 219 8.6k
Stefan G. Hübscher United Kingdom 70 8.2k 1.4× 6.9k 1.7× 1.9k 0.6× 5.1k 1.8× 1.9k 1.4× 230 15.3k

Countries citing papers authored by Laura Rubbia‐Brandt

Since Specialization
Citations

This map shows the geographic impact of Laura Rubbia‐Brandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Rubbia‐Brandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Rubbia‐Brandt more than expected).

Fields of papers citing papers by Laura Rubbia‐Brandt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Rubbia‐Brandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Rubbia‐Brandt. The network helps show where Laura Rubbia‐Brandt may publish in the future.

Co-authorship network of co-authors of Laura Rubbia‐Brandt

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Rubbia‐Brandt. A scholar is included among the top collaborators of Laura Rubbia‐Brandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Rubbia‐Brandt. Laura Rubbia‐Brandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bresson‐Hadni, Solange, et al.. (2025). Alveolar echinococcosis in the canton of Geneva between 2010 and 2021: a descriptive analysis. Swiss Medical Weekly. 155(2). 3863–3863. 1 indexed citations
2.
Bouguerra, R, Charles‐Henri Wassmer, Beat Moeckli, et al.. (2025). Hepatectomy alters adjuvant anti–PD-1 action in a mouse model of HCC but does not compromise neoadjuvant efficacy. Hepatology.
3.
Norkin, Maxim, Thibaud Koessler, Thomas McKee, et al.. (2023). Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma. Journal of Experimental & Clinical Cancer Research. 42(1). 79–79. 19 indexed citations
4.
Moeckli, Beat, Vaihere Delaune, Julien Prados, et al.. (2022). Impact of Maternal Obesity on Liver Disease in the Offspring: A Comprehensive Transcriptomic Analysis and Confirmation of Results in a Murine Model. Biomedicines. 10(2). 294–294. 11 indexed citations
5.
Fournier, E., Giacomo Puppa, Thomas McKee, et al.. (2022). Cohort profile: population-based cohorts of patients with colorectal cancer and of their relatives in Geneva, Switzerland. BMJ Open. 12(8). e063914–e063914.
6.
Orci, Lorenzo A., Mario Kreutzfeldt, Nicolas Goossens, et al.. (2019). Tolerogenic properties of liver macrophages in non‐alcoholic steatohepatitis. Liver International. 40(3). 609–621. 8 indexed citations
7.
Restellini, Sophie, Nicolas Goossens, Sophie Clément, et al.. (2018). Collagen proportionate area correlates to hepatic venous pressure gradient in non-abstinent cirrhotic patients with alcoholic liver disease. World Journal of Hepatology. 10(1). 73–81. 10 indexed citations
8.
Gonelle‐Gispert, Carmen, Stéphanie Lacotte, Ariane de Agostini, et al.. (2016). Enoxaparin Attenuates Mouse Colon Cancer Liver Metastases by Inhibiting Heparanase and Interferon-γ-inducible Chemokines.. PubMed. 36(8). 4019–32. 7 indexed citations
9.
Gariani, Karim, Dongryeol Ryu, Keir J. Menzies, et al.. (2016). Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease. Journal of Hepatology. 66(1). 132–141. 129 indexed citations
10.
Rougemont, Anne‐Laure, Fernando Álvarez, Valérie A. McLin, et al.. (2015). Bile Ducts in Regenerative Liver Nodules of Alagille Patients Are Not the Result of Genetic Mosaicism. Journal of Pediatric Gastroenterology and Nutrition. 61(1). 91–93. 7 indexed citations
11.
Tille, Jean‐Christophe, Jens Lamerz, Thomas McKee, et al.. (2015). Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues. Molecular & Cellular Proteomics. 14(10). 2786–2799. 35 indexed citations
12.
Goossens, Nicolas, Yujin Hoshida, Won‐Min Song, et al.. (2015). Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery. Clinical Gastroenterology and Hepatology. 14(11). 1619–1628. 38 indexed citations
13.
Lanthier, Nicolas, Sylvain Terraz, Romain Bréguet, et al.. (2013). Computed tomography derived liver volume: a prognostic factor in decompensated alcoholic cirrhosis?. Acta gastro-enterologica belgica. 76. 12. 1 indexed citations
14.
Schwarz, Roderich E., Jordan Berlin, Heinz Josef Lenz, et al.. (2012). Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement. HPB. 15(2). 106–115. 40 indexed citations
15.
Rubbia‐Brandt, Laura, Sébastien Tauzin, Catherine Brézault, et al.. (2011). Gene Expression Profiling Provides Insights into Pathways of Oxaliplatin-Related Sinusoidal Obstruction Syndrome in Humans. Molecular Cancer Therapeutics. 10(4). 687–696. 47 indexed citations
16.
Peyrou, Marion, Lucie Bourgoin, David M. Suter, et al.. (2011). 810 DOWNREGULATION OF PTEN AND IRS1 BY HCV 3A CORE PROTEIN TRIGGERS STEATOSIS IN HEPATOCYTES. Journal of Hepatology. 54. S325–S325. 1 indexed citations
17.
Nathan, Hari, Gilles Mentha, Hugo P. Marques, et al.. (2009). Comparative performances of staging systems for early hepatocellular carcinoma. HPB. 11(5). 382–390. 20 indexed citations
18.
Vinciguerra, Manlio, Antonino Sgroi, Christelle Veyrat‐Durebex, et al.. (2008). Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes # †. Hepatology. 49(4). 1176–1184. 167 indexed citations
19.
Rubbia‐Brandt, Laura & Antoine Hadengue. (2005). Stéatose hépatique non alcoolique : faut-il biopsier ?. Revue Médicale Suisse. 1(43). 2804–2808. 1 indexed citations
20.
Rubbia‐Brandt, Laura, Gilles Mentha, Alexis Desmoulière, et al.. (1997). Hepatic stellate cells reversibly express α-smooth muscle actin during acute hepatic ischemia. Transplantation Proceedings. 29(5). 2390–2395. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026